Gelsemium Sempervirens in Anticipatory Anxiety

PHASE3CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

May 31, 2010

Conditions
Anxiety
Interventions
DRUG

Gelsemium Sempervirens

5CH, one dose of globules morning and evening during 2 days plus one dose the morning of the day of the stress-test.

DRUG

Gelsemium Sempervirens

15CH, one dose of globules morning and evening during 2 days plus one dose the morning of the day of the stress-test.

DRUG

Placebo

placebo, one dose of globules morning and evening during 2 days plus one dose the morning of the day of the stress-test.

Trial Locations (1)

38043

Clinical Research Center, Grenoble

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

BOIRON

INDUSTRY

lead

University Hospital, Grenoble

OTHER

NCT00914329 - Gelsemium Sempervirens in Anticipatory Anxiety | Biotech Hunter | Biotech Hunter